Company / Cash & Equivalents
eHealth, Inc. Cash & Equivalents History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$73.7M
FY2025
5-year range
$39.2M / $144.4M
FY2021-FY2025
Trend
+88.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2025 after 2 years of decline, reaching $74M.
Based on SEC 10-K filings.
$74M in FY2025 with a 10-year CAGR of -3.7%.
Declined from $116M to $74M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -20.1%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -3.7%
Key checks
Key Insights
- 5-year CAGR of +11.0%, indicating consistent growth.
- In FY2025, cash & equivalents increased 88.1% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
- Lowest cash & equivalents in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $73.7M | +88.1% |
| FY2024 | $39.2M | -66.1% |
| FY2023 | $115.7M | -19.9% |
| FY2022 | $144.4M | +76.3% |
| FY2021 | $81.9M | +87.2% |
| FY2020 | $43.8M | +86.5% |
| FY2019 | $23.5M | +79.3% |
| FY2018 | $13.1M | -74.5% |
| FY2016 | $51.4M | -52.0% |
| FY2015 | $107.1M | -24.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026